-
Vericel appoints CMO: 3 details
Dr. Jonathan Hopper joined Vericel Corp., as the company's new CMO. -
17 key players in the global spine biologics market
The global spine biologics market is expected to grow at a 4.4 percent compound annual growth rate to reach more than $2.6 billion by 2022, according to a Market Research Engine report. -
Paragon 28 launches bone graft harvesting system for foot and ankle: 4 insights
Paragon 28 released its bone graft harvesting system, which is designed to improve foot and ankle surgical outcomes. -
BioRestorative Therapies publishes study examining stem cell treatment for DDD
BioRestorative Therapies' study, which evaluates the benefits of long-term hypoxic culturing of human bone marrow-dervied mesenchymal stem cells to treat disc and spine diseases, was published in the Journal of Translational Medicine. -
Steadman Philippon Research Institute to host Vail Scientific Summit: 4 things to know
The Steadman Philippon Research Institute's fourth annual Vail Scientific Summit is Aug. 19-21 in Vail, Colo., and it will focus on the clinical advances made in the study of biologics and cell therapy. -
U of Minnesota 3D-prints stem cells for spinal cord repair: 5 things to know
Minneapolis-based University of Minnesota researchers used 3D-printing technology to print stem cell-infused scaffolds that may be implanted in spinal cords to alleviate nerve damage, the StarTribune reports. -
Key trends in cartilage repair for orthopedics: Q&A with Dr. Eric Strauss
Co-Founder of the New York Cartilage Repair Society Eric Strauss, MD, an orthopedic surgeon with New York City-based NYU Langone Health, discusses the society and biggest trends in cartilage repair today. -
18 major players in the global spine biologics market
The global spine biologics market is predicted to reach $2.7 billion by 2024, growing at a 4.4 percent compound annual growth rate, according to a Data Bridge Market Research report. -
Crocodiles may be the future of cartilage repair — 4 things to know about a new technology
Researchers at Central Queensland University in Australia are developing a 3D bioprint of crocodile cartilage to promote cartilage repair, ABC Capricornia reports. -
UC San Diego scientists derive spinal cord stem cells: 4 insights
UC San Diego researchers successfully derived spinal cord neural stem cells from human pluripotent stem cells, according to research published in Nature Methods. -
Dr. Kevin Pauza certifies 14 spine physicians in Discseel procedure
To meet the growing demand for alternatives to spinal fusion, Kevin Pauza, MD, certified 14 spine specialists to perform the Discseel procedure at Weill Cornell Brain and Spine Center in New York City. -
12 major players in the global platelet rich plasma market
The global platelet rich plasma market is projected to increase from 2018 through 2026 at a 13.3 percent compound annual growth rate, according to a Credence Research report. -
3 things to know about SpinalCyte CEO Pete O'Heeron
Pete O'Heeron is the founder and CEO of SpinalCyte. -
RTI Surgical & Aziyo Biologics ink deal: 4 things to know
Aziyo Biologics will exclusively distribute its bone repair product ViBone through RTI Surgical in the U.S. -
Asterias Biotherapeutics' stem cell-derived treatment for spinal cord injury holds promise: 4 things to know
Asterias Biotherapeutics provided an update from its ongoing phase 1/2a clinical trial of a stem cell treatment for severe spinal cord injury. -
Ortho RTi receives extension on 2.1M+ warrants: 3 observations
Ortho Regenerative Technologies earned extensions of expiry dates on certain warrants. -
Appalachian Orthopedics' surgeons perform cartilage restoration procedures: 3 insights
Johnson City, Tenn.-based Appalachian Orthopedics now offers cartilage restoration procedures. -
3 things to know about Tom Cycyota, AlloSource president & CEO
Tom Cycyota is the president and CEO of AlloSource. -
5 things to know about BioRestorative Therapies
BioRestorative Therapies develops stem cell treatments for chronic back pain caused by disc degeneration. -
1st patient enrolled in Cerapedics' TLIF clinical trial: 5 takeaways
Cerapedics began its investigational device exemption clinical trial for its P-15L Peptide Enhanced Bone Graft.
Page 29 of 34